Sofosbuvir’s hepatoprotective efficacy in rats is enhanced by encapsulating in taurocholate-stabilized galactose-anchored bilosomes

Abstract Background In conjunction with other antiviral medicines, sofosbuvir (SOF) is an essential therapy for chronic hepatitis C. There is some debate over its influence on hepatic fibrosis. The use of nanotechnology in treatment has gained popularity, with the goal of delivering therapeutic subs...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Marwa Khaled Mohsen, Soheir Abo El azm Diab, Amani N. Shafik, Ahmed H. Osman, Marianne J. Naguib, Amira M. Kamel, Marwa Nagi Mehesen
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	SpringerOpen 2025-02-01
Цуврал:	Future Journal of Pharmaceutical Sciences
Нөхцлүүд:	Bilosomal formulation Galactose Taurocholate Hepatic fibrosis Sofosbuvir Thioacetamide
Онлайн хандалт:	https://doi.org/10.1186/s43094-025-00775-w
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!